|
|
|
содержание .. 209 210 211 212 ..
СЕКЦИЯ 9 ИНТЕРВЕНЦИОННОЕ ЛЕЧЕНИЕ ИБС
848 __________ Q ИНТЕРВЕНЦИОННОЕ ЛЕЧЕНИЕ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА 51. Hall P., Nakamura S., Maiello L. et al. (1996) A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after 52. Haycraft J. (1884) On the action of a secretion from the medicinal leech on the coagulation of blood. Proc. R. Soc. Lond. Ser. B., 36: 478–487. 53. Kahn J.K., Rutherford B.D., McConahay D.R. (1990) Supported «high risk» coronary angioplasty intra-aortic balloon pump counterpulsation. J. Am. Coll. 54. Kantrowitz A., Wasfi e T., Freed P.S. et al. (1986) Intra-aortic balloon pumping 1967 through 1982: Analysis of complications in 733 patients. Am. J. Cardiol., 55. Karsch K.R., Preisack M.B., Baildon R. et al. (1996) Eow molecular weight heparin (revipann) percutaneous translummal coronary angioplasty Results of 56. Kereiakes D.J., Emcoff A.M., Miller D.P. et al. (1998) Abciximab therapy and unplanned coronary stent deployment favorable effects on stent use, clinical 57. Koch K.T., Piek J.J., de Winter R.J. et al. (1999) Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose 58. Kormos R.L. (1987) The role of the intra-aortic balloon as a bridge to cardiac transplantation. Cardiac. Assists., 3(2): 1–4. 59. Kramer R.P. (1988) J. Helicopter- transported intra-aortic balloon pumping: Advanced technology made airborne. Cardiac. Assists., 4(2). 60. Kuntz R., Baim D., Popma J. et al. (1997) Late clinical results of the stent anticoagulation regimen study (STARS) (abstract). Circulation, 96(Suppl.): I 594. 61. Lablanche J.M., McFadden E.P., Meneveau N. et al. (1997) Effect of nadroparin, a low molecular weight heparin, on clinical and angiographic 62. Lane A.S., Woodward A.C., Goldman M.R. (1987) Massive propranolol overdose poorly responsive to pharmacologic therapy: Use of the intra-aortic 63. Lefkovits J., Topol E. (1999) Role of platelet inhibitor agents in coronary artery disease: In Topol E., (Еd.) Textbook of Interventional Cardiology 3rd edn 64. Lembo N.J. (1989) Failed angioplasty and intra-aortic balloon pumping. Cardiac. Assists., 5(1): 5–7. 65. Leon M.B., Baim D.S., Popma J.J. et al. (1998) A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting Stent Anticoagulation 66. Leon M.B., Popma J.J., Gordon P.C. et al. (1998) A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting Stent Anticoagulation 67. Lincoff A.M., Cahff R.M., Mohterno D.J, et al. (1999) Complementary clinical benefi ts of coronary artery stenting and blockade of platelet glycoprotein IIb/ 68. Maalej N., Folts J. (1996) Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries. 69. Maccioli G.A., Lucas W.J., Norfl eet E.A. (1988) The intra-aortic balloon pump: A review. J. Cardiother. Anesth., 2: 365–373. 70. Mangano D.T., Browner W.S., Hollenberg M. (1990) Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men 71. Mehan V.K., Saizmann C., Kaufmann U. et al. (1995) Coronary stenting without anticoagulation. Cathet. Cardiovasc. Diagn., 34: 137–140. 72. Mehran R., Popma J., Baim D. et al. (1998) Routine high pressure post stent dilatation did not infl uence clinical restenosis in STARS (abstract). J. Am. Coll. 73. Mercer D., Doris P., Salerno T.A. (1981) Intra-aortic balloon counterpulsation in septic shock. Can. J. Surg., 24(6): 643–645. 74. Moliterno D. (1999) Anticoagulants and their use in acute coronary syndromes: In: Topol E, Textbook of Interventional Cardiology 3rd edn Philadelphia WB 75. Nanns C., Hillegass W., Nelson C. et al. (1996) Relation between activated clotting time during angioplasty and abrupt closure. Circulation, 93: 667–671. 76. Ohman M.E., Califf R.M., George B.S. et al. (1991) The use of intra-aortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial 77. Patrono C. (1994) Aspirin as an antiplatelet drug. N. Engl. J. Med., 330: 1287– 1294. 78. Pennington D.G., Swartz M.T. (1990) Mechanical circulatory support prior to cardiac transplantation. Sem. Thor.&Cardiovasc. Surg., 2(2): 125–134. 79. Pepme C.J., Holmes D.R. Jr. (1996) Coronary artery stents American College of Cardiology. J. Am. Coll. Cardiol., 28: 782–794. 80. Placebo controlled trial Randomised of effect of eptifi batide on complications of percutaneous coronary intervention IMPACT II Integnlin to Minimise Platelet 81. Povenmire-lzor K., House M.A. (1989) Acute crack cocaine intoxication: A case study. Focus Crit. Care., 16(2): 112–119. 82. Preiss J., Lecompte T., Ainot Y. (1996) Serial antiplatelet effects of combined treatment with ticlopidine and aspirin after stent implantation (abstract). 83. Qumn M.J., Fitzgerald D.J. (1999) Ticlopidine and clopidogrel. Circulation, 100: 1667–1672. 84. Randomised placebo controlled and balloon angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa 85. Rodnguez J., Fernandez Jurado A. et al. (1994) Ticlopidine and severe aplastic anemia (letter). Am. J. Hematol., 47: 332. 86. Rupprecht H.J., Darius H., Borkowski U. et al. (1998) Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. 87. Schomig A., Neumann F.J., Kastrati A. et al. (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery 88. Serruys P.W., de Jaegere P., Kiemeneij F. et al. (1994) A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary 89. Serruys P.W., di Mario C., Piek J. et al. (1997) Prognostic value of Intracoronary fl ow velocity and diameter stenosis in the short-and long-terin outcomes of 90. Serruys P.W., Herrman J.P., Simon R. et al. (1995) A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty Helvetica 91. Serruys P.W., van Hout B., Bonnier H. et al. (1998) Randomised comparison of implantation of hepann coated stents with balloon angioplasty in selected 92. Shah P.B., Ahmed W.H., Ganz P. et al. (1997) Bivalirudm compared with heparin during coronary angioplasty for thrombus containing lesions. J. Am. 93. Stemhubl S.R., Lauer M.S., Mukherjee D.P. et al. (1998) The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure related non Q 94. Szto G., Lmnemeier T., Lewis S. et al. (1998) Safety of 10 days of ticlopidine after coronary stenting a randomized comparison with 30 days Strategic Alternatives 95. The EPILOG Investigators (1997) Effect of the platelet glycoprotein IIb/IIIa receptor inhibitor abciximab with lower heparin dosages on ischemic complications 96. Topol E.J., Cahff R.M., Weisman H.F. et al. (1994) Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical 97. Topol E.J., Ferguson J.J., Weisman H.F. et al. (1997) Long term protection from myocardial ischemic events in a randomized trial of brief integrin beta 98. Use of a monoclonal antibody directed against the platelet glycoprotem IIb/ IIIa receptor in high risk coronary angioplasty The EPIC Investigation (1994). 99. Van de Loo A., Nauck M., Noory E. et al. (1998) Enhancement of platelet inhibition of ticlopidine plus aspirin versus aspirin alone given prior to elective 100. Van den Bos A.A., Deckers J.W., Heyndnck G.R. et al. (1993) Safety and effi cacy of recombmant hirudin (CGP 39 393) versus heparin in patients with 101. Wolvek S. (1989) The evolution of the intra-aortic balloon: The Datascope contribution. J. Biomaterials. AppI., 3: 527–542. |